Notably, Akt3 mRNA levels are comparable with Akt2 levels (TCGA, Supplementary Figure S6D) in prostate cancer, suggesting a tight post-transcriptional regulation to limit its protein levels in tumors. The gene discussed is AKT3; the disease is prostate carcinoma.